{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:53:27Z","timestamp":1758394407159},"reference-count":48,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.jim.2005.11.005","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T23:18:40Z","timestamp":1135293520000},"page":"216-230","source":"Crossref","is-referenced-by-count":11,"title":["Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Concomitant assessment of perforin, IFN-\u03b3 and IL-4 secretion"],"prefix":"10.1016","volume":"308","author":[{"given":"Catherine T.","family":"Burton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Gotch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrina","family":"Imami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6802","key":"10.1016\/j.jim.2005.11.005_bib1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/35030124","article-title":"Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia","volume":"407","author":"Allen","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jim.2005.11.005_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function","volume":"192","author":"Appay","year":"2000","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jim.2005.11.005_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/314831","article-title":"Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with <\/=250\/microL CD4 T cells and undetectable plasma virus load","volume":"180","author":"Arno","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"1\u20133","key":"10.1016\/j.jim.2005.11.005_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-2478(98)00159-X","article-title":"Restoration of the immune system with anti-retroviral therapy","volume":"66","author":"Autran","year":"1999","journal-title":"Immunol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.jim.2005.11.005_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.jim.2005.11.005_bib6","first-page":"181","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs","volume":"14","author":"Brunner","year":"1968","journal-title":"Immunology"},{"issue":"6824","key":"10.1016\/j.jim.2005.11.005_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35065118","article-title":"Skewed maturation of memory HIV-specific CD8 T lymphocytes","volume":"410","author":"Champagne","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jim.2005.11.005_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-5699(93)90208-3","article-title":"A Th1 to Th2 switch is a critical step in the etiology of HIV infection","volume":"14","author":"Clerici","year":"1993","journal-title":"Immunol. Today"},{"issue":"1\u20132","key":"10.1016\/j.jim.2005.11.005_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.jim.2005.11.005_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.284.2.183","article-title":"Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial","volume":"284","author":"Davey","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jim.2005.11.005_bib11","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.4049\/jimmunol.173.9.5372","article-title":"Vaccination in humans generates broad T cell cytokine responses","volume":"173","author":"De Rosa","year":"2004","journal-title":"J. Immunol."},{"issue":"6884","key":"10.1016\/j.jim.2005.11.005_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jim.2005.11.005_bib13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.78.2.630-641.2004","article-title":"Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection","volume":"78","author":"Draenert","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2005.11.005_bib14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.4049\/jimmunol.165.2.1082","article-title":"Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-tern nonprogressors","volume":"165","author":"Gea-Banacloche","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2005.11.005_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.humimm.2004.02.012","article-title":"Cytomegalovirus (CMV)-specific cellular immune responses","volume":"65","author":"Harari","year":"2004","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2005.11.005_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.174.2.1037","article-title":"Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence","volume":"174","author":"Harari","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jim.2005.11.005_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2249.2003.02256.x","article-title":"Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness","volume":"134","author":"Hardy","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"16","key":"10.1016\/j.jim.2005.11.005_bib17","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/00002030-200411050-00014","article-title":"Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses.","volume":"18","author":"Hardy","year":"2004","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jim.2005.11.005_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/aid.1996.12.585","article-title":"Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type-1 infection","volume":"12","author":"Harrer","year":"1996","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"1","key":"10.1016\/j.jim.2005.11.005_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2249.1999.01012.x","article-title":"Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy","volume":"118","author":"Imami","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jim.2005.11.005_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-2478(01)00267-X","article-title":"Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination","volume":"79","author":"Imami","year":"2001","journal-title":"Immunol. Lett."},{"issue":"18","key":"10.1016\/j.jim.2005.11.005_bib22","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1128\/JVI.76.18.9011-9023.2002","article-title":"A balanced type 1\/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection","volume":"76","author":"Imami","year":"2002","journal-title":"J.Virol."},{"issue":"5","key":"10.1016\/j.jim.2005.11.005_bib23","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.181.5.1755","article-title":"Interleukin 12 signaling in T helper type 1 (Th1) cells involves phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4","volume":"181","author":"Jacobson","year":"1995","journal-title":"J. Exp. Med."},{"issue":"6925","key":"10.1016\/j.jim.2005.11.005_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jim.2005.11.005_bib25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/383227","article-title":"Distinct patterns of peripheral HIV-1-specific interferon-gamma responses in exposed HIV-1-seronegative individuals","volume":"189","author":"Kebba","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jim.2005.11.005_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.186.6.859","article-title":"Rapid effector function in CD8+ memory T cells","volume":"186","author":"Lalvani","year":"1997","journal-title":"J. Exp. Med."},{"issue":"9117","key":"10.1016\/j.jim.2005.11.005_bib27","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","article-title":"Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease","volume":"351","author":"Li","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2005.11.005_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmv.1890430119","article-title":"Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes","volume":"43","author":"McLaughlin-Taylor","year":"1994","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.jim.2005.11.005_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.jim.2005.11.005_bib30","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/00002030-200102002-00004","article-title":"Cellular immune response to human immunodeficiency virus","volume":"15","author":"Norris","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jim.2005.11.005_bib31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA","volume":"279","author":"Ogg","year":"1998","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.jim.2005.11.005_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jim.2005.11.005_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/088922203762688603","article-title":"Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and\/or with HIV type 1 immunogen (Remune)","volume":"19","author":"Pido-Lopez","year":"2003","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jim.2005.11.005_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2005.11.005_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/314599","article-title":"Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens","volume":"179","author":"Rinaldo","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"5342","key":"10.1016\/j.jim.2005.11.005_bib36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"issue":"1\u20133","key":"10.1016\/j.jim.2005.11.005_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-2478(98)00179-5","article-title":"Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors","volume":"66","author":"Rowland-Jones","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jim.2005.11.005_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0966-842X(03)00066-0","article-title":"Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence","volume":"11","author":"Scholz","year":"2003","journal-title":"Trends Microbiol."},{"issue":"5617","key":"10.1016\/j.jim.2005.11.005_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.jim.2005.11.005_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-1759(00)00329-X","article-title":"A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis","volume":"249","author":"Sheehy","year":"2001","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.jim.2005.11.005_bib41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00002030-200303070-00020","article-title":"Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy","volume":"17","author":"Sullivan","year":"2003","journal-title":"AIDS"},{"issue":"5617","key":"10.1016\/j.jim.2005.11.005_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jim.2005.11.005_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jim.2005.11.005_bib44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/1074-7613(95)90011-X","article-title":"Developmental commitment to the Th2 lineage by extinction of IL-12 signaling","volume":"2","author":"Szabo","year":"1995","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jim.2005.11.005_bib45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.185.5.817","article-title":"Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells","volume":"185","author":"Szabo","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2005.11.005_bib46","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/JVI.70.11.7569-7579.1996","article-title":"The human cytotoxic T-lymphocytes (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.jim.2005.11.005_bib47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1086\/315764","article-title":"Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease","volume":"182","author":"Wilson","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jim.2005.11.005_bib48","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1084\/jem.20031598","article-title":"HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity","volume":"198","author":"Younes","year":"2003","journal-title":"J. Exp. Med."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175905003996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175905003996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:30:41Z","timestamp":1586633441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175905003996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":48,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0022175905003996"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2005.11.005","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}